Zinc Acetate Dispersible Tablets

1. Product Introduction

Zinc Acetate Dispersible Tablets are oral mineral supplements supplied in two labelled strengths, providing 10 mg or 20 mg elemental zinc per tablet. The tablet is dispersed in a small amount of suitable liquid before administration according to the approved instructions. Healthy Life Pharma Pvt. Ltd. is identified as manufacturer and Healthy Inc as exporter in the supplied brief.

Zinc is required for normal immune function, growth, wound healing and enzyme activity. Zinc supplementation is an established component of management of acute childhood diarrhea alongside oral rehydration therapy in settings where recommended. It does not replace fluids or assessment for dehydration.

2. Product Specifications

Therapeutic category: Mineral supplement. Salt: Zinc acetate (BP ingredient standard as supplied). SKU: Zinc Acetate Tablets.

The separate marketing description mentions 50 mg elemental zinc, 36-month shelf life and specific packaging; these are not confirmed for the two labelled products. BP ingredient designation does not alone verify finished-product BP compliance.

3. Manufacturing Technology

Dispersible zinc formulations require attention to dose uniformity, palatability, disintegration/dispersibility, and protection from moisture. Appropriate manufacturing controls may include validated blending, tablet compression, humidity management and compatibility checks for approved flavours and colours.

Exact process equipment, comparative taste superiority, Mumbai facility details and WHO-GMP status should be supported by current manufacturing and certification records rather than inferred from general marketing copy.

4. Quality Assurance

• Identity and assay of zinc acetate and verification of the labelled elemental zinc content using a validated analytical method appropriate for inorganic zinc (not assumed to be HPLC).
• Tablet mass variation/content uniformity, as applicable.
• Dispersibility and disintegration testing against the approved specification.
• Moisture, stability, microbiological quality and packaging compatibility where required.

Actual acceptance criteria, expiry date and stability claims require approved batch and stability documents.

5. Therapeutic Uses and Nutritional Role

• Acute childhood diarrhea: Zinc is commonly recommended as an adjunct to oral rehydration solution (ORS), with age-appropriate elemental-zinc dosing under local guidance.
• Zinc deficiency: May be used where deficiency or increased requirement is identified.
• Normal growth and immunity: Zinc supports multiple enzymes and normal immune function.

Wilson disease distinction: Zinc salts can be used in specialist treatment of Wilson disease, but these 10 mg/20 mg dispersible supplements are not established as equivalent to an approved Wilson-disease zinc acetate regimen. Wilson disease requires disease-specific dosing, monitoring and specialist care. Do not promote these SKUs as direct Wilson-disease treatment without product-specific approval.

6. Export and Regulatory Support

For procurement, request approved composition, product registration details, certificate of analysis, stability data, approved artwork and applicable manufacturing licenses. CTD/ACTD dossiers, COPP, FSC, WHO-GMP certificates, export destination authorizations and packaging configurations must be confirmed before being offered as available.

For B2B enquiries contact +91 7710003340.

7. Frequently Asked Questions

Q: What are the labelled strengths?
A: 10 mg and 20 mg elemental zinc per tablet, supplied as zinc acetate BP.

Q: How is a dispersible tablet given?
A: Disperse in a small amount of water or other suitable liquid according to the approved product directions and administer the full dose promptly.

Q: Is zinc acetate always better tolerated than zinc sulfate?
A: Tolerability varies; a general claim of superiority is not established by the supplied information.

Q: Is the 50 mg strength available?
A: The supplied explicit compositions confirm only 10 mg and 20 mg; 50 mg requires separate verification.

Q: Can this be used to treat Wilson disease?
A: Not as a substitute for a specialist-prescribed, approved Wilson-disease regimen.

8. Dosage and Administration

For acute childhood diarrhea, commonly used WHO guidance recommends 10 mg elemental zinc daily for infants under 6 months and 20 mg daily for children 6 months and older, typically for 10–14 days, alongside ORS; follow current local clinical guidelines and the product label.

Disperse the prescribed tablet in a small amount of clean water or an approved liquid, and administer the complete prepared dose. Seek medical attention for dehydration, blood in stool, persistent vomiting, lethargy or inability to drink. Wilson-disease dosing is entirely separate and specialist-directed.

9. Side Effects and Precautions

• Possible adverse effects include nausea, vomiting, abdominal discomfort and unpleasant taste.
• Excessive or prolonged zinc intake can cause copper deficiency and related hematological or neurological problems.
• Zinc can reduce absorption of certain antibiotics (such as tetracyclines and quinolones); dose separation may be required.
• Use in infants, pregnancy or patients with chronic disease should follow an appropriate clinical recommendation.
• Do not assume a universal one-hour-before/after-food instruction; this depends on indication and approved label.

10. Storage Instructions

Keep tablets in the original packaging, protected from moisture and excessive heat. Follow the approved label for temperature limits and expiry; a universal below-25°C requirement and 36-month shelf life were not established by the supplied 10 mg and 20 mg compositions.

Keep out of reach of children.